CRISPR-based functional genomics in human dendritic cells

Dendritic cells (DCs) regulate processes ranging from antitumor and antiviral immunity to host-microbe communication at mucosal surfaces. It remains difficult, however, to genetically manipulate human DCs, limiting our ability to probe how DCs elicit specific immune responses. Here, we develop a CRI...

Full description

Bibliographic Details
Main Authors: Marco Jost, Amy N Jacobson, Jeffrey A Hussmann, Giana Cirolia, Michael A Fischbach, Jonathan S Weissman
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-04-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/65856
id doaj-af2eea39e034442491abb1656b561b49
record_format Article
spelling doaj-af2eea39e034442491abb1656b561b492021-05-07T15:31:47ZengeLife Sciences Publications LtdeLife2050-084X2021-04-011010.7554/eLife.65856CRISPR-based functional genomics in human dendritic cellsMarco Jost0https://orcid.org/0000-0002-1369-4908Amy N Jacobson1Jeffrey A Hussmann2Giana Cirolia3Michael A Fischbach4Jonathan S Weissman5https://orcid.org/0000-0003-2445-670XDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States; California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United StatesDepartment of Bioengineering, Stanford University, Stanford, United States; ChEM-H, Stanford University, Stanford, United StatesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States; California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States; Whitehead Institute for Biomedical Research, Cambridge, United StatesChan Zuckerberg Biohub, San Francisco, United StatesDepartment of Bioengineering, Stanford University, Stanford, United States; ChEM-H, Stanford University, Stanford, United States; Chan Zuckerberg Biohub, San Francisco, United StatesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States; California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States; Whitehead Institute for Biomedical Research, Cambridge, United States; Department of Biology, Massachusetts Institute of Technology, Cambridge, United StatesDendritic cells (DCs) regulate processes ranging from antitumor and antiviral immunity to host-microbe communication at mucosal surfaces. It remains difficult, however, to genetically manipulate human DCs, limiting our ability to probe how DCs elicit specific immune responses. Here, we develop a CRISPR-Cas9 genome editing method for human monocyte-derived DCs (moDCs) that mediates knockouts with a median efficiency of >94% across >300 genes. Using this method, we perform genetic screens in moDCs, identifying mechanisms by which DCs tune responses to lipopolysaccharides from the human microbiome. In addition, we reveal donor-specific responses to lipopolysaccharides, underscoring the importance of assessing immune phenotypes in donor-derived cells, and identify candidate genes that control this specificity, highlighting the potential of our method to pinpoint determinants of inter-individual variation in immunity. Our work sets the stage for a systematic dissection of the immune signaling at the host-microbiome interface and for targeted engineering of DCs for neoantigen vaccination.https://elifesciences.org/articles/65856CRISPRdendritic cellsbacteroides thetaiotaomicronfunctional genomicsinter-individual variation
collection DOAJ
language English
format Article
sources DOAJ
author Marco Jost
Amy N Jacobson
Jeffrey A Hussmann
Giana Cirolia
Michael A Fischbach
Jonathan S Weissman
spellingShingle Marco Jost
Amy N Jacobson
Jeffrey A Hussmann
Giana Cirolia
Michael A Fischbach
Jonathan S Weissman
CRISPR-based functional genomics in human dendritic cells
eLife
CRISPR
dendritic cells
bacteroides thetaiotaomicron
functional genomics
inter-individual variation
author_facet Marco Jost
Amy N Jacobson
Jeffrey A Hussmann
Giana Cirolia
Michael A Fischbach
Jonathan S Weissman
author_sort Marco Jost
title CRISPR-based functional genomics in human dendritic cells
title_short CRISPR-based functional genomics in human dendritic cells
title_full CRISPR-based functional genomics in human dendritic cells
title_fullStr CRISPR-based functional genomics in human dendritic cells
title_full_unstemmed CRISPR-based functional genomics in human dendritic cells
title_sort crispr-based functional genomics in human dendritic cells
publisher eLife Sciences Publications Ltd
series eLife
issn 2050-084X
publishDate 2021-04-01
description Dendritic cells (DCs) regulate processes ranging from antitumor and antiviral immunity to host-microbe communication at mucosal surfaces. It remains difficult, however, to genetically manipulate human DCs, limiting our ability to probe how DCs elicit specific immune responses. Here, we develop a CRISPR-Cas9 genome editing method for human monocyte-derived DCs (moDCs) that mediates knockouts with a median efficiency of >94% across >300 genes. Using this method, we perform genetic screens in moDCs, identifying mechanisms by which DCs tune responses to lipopolysaccharides from the human microbiome. In addition, we reveal donor-specific responses to lipopolysaccharides, underscoring the importance of assessing immune phenotypes in donor-derived cells, and identify candidate genes that control this specificity, highlighting the potential of our method to pinpoint determinants of inter-individual variation in immunity. Our work sets the stage for a systematic dissection of the immune signaling at the host-microbiome interface and for targeted engineering of DCs for neoantigen vaccination.
topic CRISPR
dendritic cells
bacteroides thetaiotaomicron
functional genomics
inter-individual variation
url https://elifesciences.org/articles/65856
work_keys_str_mv AT marcojost crisprbasedfunctionalgenomicsinhumandendriticcells
AT amynjacobson crisprbasedfunctionalgenomicsinhumandendriticcells
AT jeffreyahussmann crisprbasedfunctionalgenomicsinhumandendriticcells
AT gianacirolia crisprbasedfunctionalgenomicsinhumandendriticcells
AT michaelafischbach crisprbasedfunctionalgenomicsinhumandendriticcells
AT jonathansweissman crisprbasedfunctionalgenomicsinhumandendriticcells
_version_ 1721455407081193472